Role of Renal Sonography in the Diagnosis of Chronic Kidney Disease
DOI:
https://doi.org/10.37506/hx1yjw44Keywords:
Chronic Kidney disease, cross-sectional, Renal cortical echogenicity, serum creatinine.Abstract
Aim: to use sonographic imaging in grading CKD and assess the serum creatinine, renal longitudinal size,
parenchymal thickness and compare these parameters based upon ultrasonographic grade.
Material and Methods: Present cross-sectional; study was conducted at the Department of Radiology, Tertiary Care Teaching Institute of India for the duration of 1 year. There are 120 participants with CKD in the research.
All patients received a questionnaire, and a thorough clinical examination was done. Each participant underwent sector curved array transducer of 3.5–5 MHz ultrasound images of their liver and kidneys. Low tissue harmonic and speckle reduction imaging techniques are used to measure the echogenicity of the kidney and liver while reducing interobserver bias. In all the participants, the mean values of both the kidneys renal longitudinal size and parenchymal thickness were calculated. Renal cortical echogenicity was compared and graded with the echogenicity of the liver and renal medulla.
Results: The mean age of the CKD patients was found to be 45.23 ± 06.05 years. It was found that 50 patients
had Grade 1, 40 patients had Grade 2, 20 patients had Grade 3 and 10 patients had Grade 4. The results showed that, when the comparison was done, serum creatinine was found to be significant among echogenicity grades with ANOVA. when the comparison was done; the mean longitudinal size was found to be significant among echogenicity. On comparison was found to be mean Parenchymal thickness was found to be significant among echogenicity grades.
Conclusion: Renal cortical echogenicity and its grading in relation to longitudinal length, parenchymal thickness, and cortical thickness in CKD patients are the best sonographic parameters that correlate with blood creatinine. It is possible to use renal cortical echogenicity as a metric of renal function since it has the benefit of being irreversible in compared to serum creatinine levels.
References
Vaidya, S. R.; Aeddula, N. R.: Chronic renal failure. In
StatPearls [Internet]; StatPearls Publishing, 2021.
Matovinović, M. S. J. E. 1. Pathophysiology and
classification of kidney diseases. 2009, 20, 2.
Bikbov, B.; Purcell, C. A.; Levey, A. S.; Smith, M.;
Abdoli, A.; Abebe, M.; Adebayo, O. M.; Afarideh,
M.; Agarwal, S. K.; Agudelo-Botero, M. J. T. l. Global,
regional, and national burden of chronic kidney
disease, 1990–2017: a systematic analysis for the Global
Burden of Disease Study 2017. 2020, 395, 709-733.
Kovesdy, C. P. J. K. I. S. Epidemiology of chronic
kidney disease: an update 2022. 2022, 12, 7-11.
Varma, P. J. I. j. o. n. Prevalence of chronic kidney
disease in India-Where are we heading? 2015, 25, 133.
Agarwal, S.; Srivastava, R. J. N. c. p. Chronic kidney
disease in India: challenges and solutions. 2009, 111,
c197-c203.
Król, E.; Rutkowski, B.; Czarniak, P.; Kraszewska, E.;
Lizakowski, S.; Szubert, R.; Czekalski, S.; Sułowicz,
W.; Więcek, A. J. A. j. o. n. Early detection of chronic
kidney disease: results of the PolNef study. 2009, 29,
-273.
Jankowski, J.; Floege, J.; Fliser, D.; Böhm, M.; Marx, N.
J. C. Cardiovascular disease in chronic kidney disease:
pathophysiological insights and therapeutic options.
, 143, 1157-1172.
Chen, T. K.; Knicely, D. H.; Grams, M. E. J. J. Chronic
kidney disease diagnosis and management: a review.
, 322, 1294-1304.
Kuo, C.-C.; Chang, C.-M.; Liu, K.-T.; Lin, W.-K.;
Chiang, H.-Y.; Chung, C.-W.; Ho, M.-R.; Sun, P.-R.;
Yang, R.-L.; Chen, K.-T. J. N. d. m. Automation of the
kidney function prediction and classification through
ultrasound-based kidney imaging using deep learning.
, 2, 29.
Nankivell, B. J. J. A. P. Creatinine clearance and the
assessment of renal function. 2001, 24, 15.
Singh, A.; Gupta, K.; Chander, R.; Vira, M. J. J. o. e. o.
m.; sciences, d. Sonographic grading of renal cortical
echogenicity and raised serum creatinine in patients
with chronic kidney disease. 2016, 5, 2279-2287.
Hippisley-Cox, J.; Coupland, C. J. b. Diabetes
treatments and risk of amputation, blindness, severe
kidney failure, hyperglycaemia, and hypoglycaemia:
open cohort study in primary care. 2016, 352.
Rayner, H. C.; Hollingworth, L.; Higgins, R.; Dodds, S.
J. B. q.; safety. Systematic kidney disease management
in a population with diabetes mellitus: turning the tide
of kidney failure. 2011, 20, 903-910.
Levey, A. S.; Eckardt, K.-U.; Tsukamoto, Y.; Levin,
A.; Coresh, J.; Rossert, J.; Zeeuw, D. D.; Hostetter, T.
H.; Lameire, N.; Eknoyan, G. J. K. i. Definition and
classification of chronic kidney disease: a position
statement from Kidney Disease: Improving Global
Outcomes (KDIGO). 2005, 67, 2089-2100.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.